Skip to main content
. Author manuscript; available in PMC: 2013 Jun 10.
Published in final edited form as: J Med Virol. 2011 Sep;83(9):1571–1581. doi: 10.1002/jmv.22133

Table II.

CVB1 interaction with soluble human CAR and DAF evaluated by reduction plaque assays.

Virus +hCAR +hDAF

CVB1N 2 log reductions* 1 log reductions*
CVB1Nm 2 log reductions* 0 log reductions
CVB3 2 log reductions* 0 log reductions
*

P<0.05; hCAR (human coxsackievirus-adenovirus receptor); hDAF (human decay-accelerating factor).